Skip to main content
. Author manuscript; available in PMC: 2009 Sep 23.
Published in final edited form as: Circ Res. 2008 May 23;102(10):1143–1145. doi: 10.1161/CIRCRESAHA.108.177295

Figure.

Figure

Novel signal transduction cross-talk between AT1 and AT2 in VSMCs. The Rho/Rhokinase cascade inhibition by the AT2 receptor via the “triple-twist” theory involving SHP-1, CK2 and SLK not only inhibits AT1-induced vascular contraction, but also likely inhibits VSMC hypertrophy and migration. In addition, CK2 may be activated through the AT1 receptor, and AT2-activated SHP-1 has been shown to directly inactivate EGFR to inhibit AT1-activated hypertrophic signal transduction.